Cargando…
The role of Traditional Chinese medicine in anti-HBV: background, progress, and challenges
Chronic hepatitis B (CHB) remains a major world's most serious public health issues. Despite the remarkable effect of nucleos(t)ide analogues (NAs) in inhibiting hepatitis B virus (HBV) deoxyribonucleic acid (DNA) as the first-line drug, there are several limitations still, such as poor antigen...
Autores principales: | Ge, Feilin, Yang, Yan, Bai, Zhaofang, Si, Lanlan, Wang, Xuemei, Yu, Jia, Xiao, Xiaohe, Liu, Yan, Ren, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693092/ https://www.ncbi.nlm.nih.gov/pubmed/38042824 http://dx.doi.org/10.1186/s13020-023-00861-2 |
Ejemplares similares
-
Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients
por: Liao, Hao, et al.
Publicado: (2022) -
Pharmacological effects of Chinese medicine modulating NLRP3 inflammasomes in fatty liver treatment
por: Liu, Tingting, et al.
Publicado: (2022) -
Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities
por: Zhao, Chang-qing, et al.
Publicado: (2014) -
Guidance for the clinical evaluation of traditional Chinese medicine-induced liver injuryIssued by China Food and Drug Administration
por: Xiao, Xiaohe, et al.
Publicado: (2019) -
Perceptions of traditional Chinese medicine doctors about using
wearable devices and traditional Chinese medicine diagnostic instruments: A
mixed-methodology study
por: Zhou, Siyu, et al.
Publicado: (2022)